LFMD

In a report released on November 10, David Larsen from BTIG maintained a Buy rating on LifeMD (LFMD - Research Report), with a price target of $8.00. The company's shares closed last Friday at $2.48.According to TipRanks, Larsen is an analyst with an average return of -12.1% and a 31.22% success rate. Larsen covers the Technology sector, focusing on stocks such as Signify Health, Sharecare, and Omnicell.Currently, the analyst consensus on LifeMD is a Moderate Buy with an average price target of $8.00, implying a 222.58% upside from current levels. In a report released on November 11, B.Riley Financial also maintained a Buy rating on the stock with a $8.
https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-lifemd-lfmd?utm_source=advfn.com&utm_medium=referral